In HUVEC experiments, AICAR enhanced angiogenesis through FGF21/FGFR1/PI3K/AKT/VEGF signaling.
In plain wordsIn cells, AICAR enhanced blood vessel formation through the FGF21 signaling pathway.
- Peptide
- AICAR (acadesine)
- Outcome
- IncreaseAngiogenesis
- Study
humann: not reported in source
human umbilical vein endothelial cells- Outcome group
- Angiogenesis · Cardiovascular
- Studied dose
- Dose not stated
Source sentences
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) enhanced angiogenesis and cell migration through FGF21/FGFR1/PI3K/AKT/VEGF signaling pathway.
2 context sentences(design, population, supporting numbers)
In vitro, human umbilical vein endothelial cells (HUVECs) were treated with H2O2, recombinant human FGF21 (rhFGF21), fibroblast growth factor receptor 1 (FGFR1) inhibitor (PD166866), and phosphatidylinositol 3-kinase (PI3K) inhibitor (LY294002) to explore the potential mechanisms.
Scratch wound healing and tubule formation analysis were used to detect the migration and tubule formation ability of HUVECs.